Clinical Trial Update: Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)

View source ↗

Summary

A post-marketing surveillance trial reports outcomes for newly diagnosed glioblastoma treated with radiotherapy and temozolomide, including adjuvant temozolomid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Glioblastoma | Status: COMPLETED | Results posted: 2010-04-02